Vadim Lesan

Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma

Evgenii Shumilov, Julia Katharina Scholz, Maximilian Seib et al. · Blood Advances · 2025 · 28 citations · Full text

Life Sciences, Immunology, Oncology +16

Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal Antibodies

Konstantinos Christofyllakis, Frank Neumann, Moritz Bewarder et al. · Nutrients · 2023 · 15 citations · Full text

Life Sciences, Immunology, Nutritional Sciences +14

Increased B‐cell activity with consumption of activated monocytes in severe COVID‐19 patients

Igor Age Kos, Benedikt Balensiefer, Vadim Lesan et al. · European Journal of Immunology · 2021 · 14 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

Progression-free survival estimates are shaped by specific censoring rules: Implications for PFS as an endpoint in cancer randomized trials

Vadim Lesan, Timothée Olivier, Vinay Prasad · European Journal of Cancer · 2024 · 11 citations · Full text

Public Health, Biostatistics, Oncology +11

Autoantibodies against Progranulin and IL-1 receptor antagonist due to immunogenic posttranslational isoforms contribute to hyperinflammation in critically ill COVID-19

Lorenz Thurner, Natalie Fadle, Moritz Bewarder et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 10 citations · Full text

Life Sciences, Immunology, Internal Medicine +10